
Indian pharma sector needs price hikes, site and IP transfers to tackle US tariff uncertainty: Report
New Delhi, September 9 The Indian pharmaceutical industry requires price increases, site and intellectual property (IP) transfers to deal with the prevailing uncertainty in the…